DE60004786T2 - Verfahren und zusammensetzung zur behandlung von akne - Google Patents

Verfahren und zusammensetzung zur behandlung von akne Download PDF

Info

Publication number
DE60004786T2
DE60004786T2 DE60004786T DE60004786T DE60004786T2 DE 60004786 T2 DE60004786 T2 DE 60004786T2 DE 60004786 T DE60004786 T DE 60004786T DE 60004786 T DE60004786 T DE 60004786T DE 60004786 T2 DE60004786 T2 DE 60004786T2
Authority
DE
Germany
Prior art keywords
composition
azelaic acid
benzoyl peroxide
weight
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60004786T
Other languages
German (de)
English (en)
Other versions
DE60004786D1 (de
Inventor
John Sefton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of DE60004786D1 publication Critical patent/DE60004786D1/de
Publication of DE60004786T2 publication Critical patent/DE60004786T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60004786T 1999-02-18 2000-02-15 Verfahren und zusammensetzung zur behandlung von akne Expired - Fee Related DE60004786T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/252,318 US6262117B1 (en) 1999-02-18 1999-02-18 Method and composition for treating acne
US252318 1999-02-18
PCT/US2000/003902 WO2000048567A1 (en) 1999-02-18 2000-02-15 Method and composition for treating acne

Publications (2)

Publication Number Publication Date
DE60004786D1 DE60004786D1 (de) 2003-10-02
DE60004786T2 true DE60004786T2 (de) 2004-08-19

Family

ID=22955522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60004786T Expired - Fee Related DE60004786T2 (de) 1999-02-18 2000-02-15 Verfahren und zusammensetzung zur behandlung von akne

Country Status (9)

Country Link
US (1) US6262117B1 (ja)
EP (1) EP1152748B1 (ja)
JP (1) JP2002537240A (ja)
AT (1) ATE247947T1 (ja)
AU (1) AU758594B2 (ja)
CA (1) CA2362343C (ja)
DE (1) DE60004786T2 (ja)
ES (1) ES2204552T3 (ja)
WO (1) WO2000048567A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6479060B1 (en) * 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US7074832B2 (en) 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US20030064084A1 (en) * 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
US20030138466A1 (en) * 2001-11-28 2003-07-24 Bradley Pharmaceuticals, Inc. Antioxidant dermatological composition
US6986896B2 (en) * 2002-03-20 2006-01-17 Bradley Pharmaceuticals, Inc. Method of treating fungal conditions of the skin
US6743417B2 (en) 2002-04-22 2004-06-01 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis with urea and an antioxidant
US20040156870A1 (en) * 2003-02-11 2004-08-12 Bradley Pharmaceuticals, Inc. Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs
US20050019422A1 (en) * 2003-07-23 2005-01-27 Allergan, Inc. Method and composition for treating acne
US20050074473A1 (en) * 2003-10-07 2005-04-07 Cabot Corporation Soft-focus cosmetic composition comprising fumed alumina
US8158138B1 (en) 2004-05-20 2012-04-17 Fougera Pharmaceuticals, Inc. Urea compositions and their methods of manufacture
ITMI20041567A1 (it) * 2004-07-30 2004-10-30 Maycos Italiana Di Comini Miro "derivati n-acilati di acidi bicarbossilici con amminoacidi e con idrolizzati proteici vegetali e loro applicazione in prodotti cosmetici, dermofarmaceutici e farmaceutici"
EP1954294A2 (en) 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition
US20090209604A1 (en) * 2008-02-14 2009-08-20 Jerry Zhang Topical combination therapy for treating acne
WO2010005521A1 (en) * 2008-06-30 2010-01-14 Bltn, Llc Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
WO2010080543A1 (en) 2008-12-18 2010-07-15 Guthery B Eugene Acne vulgaris treatment regimen

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849396A (en) 1973-01-08 1974-11-19 Upjohn Co Lincomycin and clindamycin 1-o-ethers
US3932653A (en) 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US3969516A (en) 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4132781A (en) 1974-12-19 1979-01-02 Nelson Research & Development Company Method for treatment of acne
US4018918A (en) 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US3991203A (en) 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4386104A (en) 1977-04-19 1983-05-31 Nazzaro Porro Marcella Process for the treatment of acne
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4505896A (en) 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4387107A (en) 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4323558A (en) 1979-09-10 1982-04-06 Nelson Research & Development Co. Topical trien containing pharmaceutical compositions and methods of use
FR2488253A1 (fr) 1980-08-08 1982-02-12 Roques Bernard Nouveaux peptides et leur application en therapeutique
US4692329A (en) 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
US4411893A (en) 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4607101A (en) 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
JPS59184135A (ja) 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
LU85111A1 (fr) * 1983-12-01 1985-09-12 Oreal Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
US4743588A (en) 1984-06-13 1988-05-10 Allergan Pharmaceuticals, Inc. Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents
JPS6160620A (ja) 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
US4621075A (en) 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
JPH0643390B2 (ja) 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
US4916118A (en) 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
FR2604357B1 (fr) 1986-09-30 1988-12-02 Oreal Composition pharmaceutique et cosmetique anti-acneique
FR2604435B1 (fr) 1986-09-30 1988-12-02 Oreal Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
US4942031A (en) 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
US5231087A (en) 1988-03-16 1993-07-27 Cellegy Pharmaceuticals, Inc. Treatment of skin diseases and tumors with esters and amides of monocarboxylic acids
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
JPH07506367A (ja) 1992-05-05 1995-07-13 ザ、プロクター、エンド、ギャンブル、カンパニー アクネ治療組成物
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
DE4307976A1 (de) * 1993-03-15 1994-09-22 Beiersdorf Ag Neue Verwendung von Aknemitteln
AU6666594A (en) 1993-04-20 1994-11-08 Procter & Gamble Company, The Methods of using hesperetin for sebum control and treatment of acne
US5538732A (en) * 1994-04-12 1996-07-23 Creative Products Resource, Inc. Medicated applicator sheet for topical drug delivery
US5516950A (en) 1994-04-15 1996-05-14 Insmed Pharmaceuticals, Inc. Method for the production of D-chiroinositol
FR2719044B1 (fr) 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
JPH10510272A (ja) * 1994-11-28 1998-10-06 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚コンディショニング剤として増粘型ポリオールカルボン酸エステルを含む局所用肌荒れ防止用組成物
US5618522A (en) 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
US5665364A (en) * 1995-07-24 1997-09-09 The Procter & Gamble Company Compositions for topical delivery of active ingredients

Also Published As

Publication number Publication date
CA2362343C (en) 2008-07-29
AU4001200A (en) 2000-09-04
EP1152748B1 (en) 2003-08-27
EP1152748A1 (en) 2001-11-14
WO2000048567A1 (en) 2000-08-24
ATE247947T1 (de) 2003-09-15
ES2204552T3 (es) 2004-05-01
CA2362343A1 (en) 2000-08-24
JP2002537240A (ja) 2002-11-05
US6262117B1 (en) 2001-07-17
AU758594B2 (en) 2003-03-27
DE60004786D1 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
DE60004786T2 (de) Verfahren und zusammensetzung zur behandlung von akne
DE2046119C2 (de) Mittel zur Behandlung von Akne
DE2913296C2 (ja)
DE602005002844T3 (de) Umkehremulsionszusammensetzung mit calcitriol und clobetasol-17-propionat und ihre kosmetische und dermatologische verwendung
DE60216634T2 (de) Gel mit mindestens einem retinoid und benzoylperoxid
EP0582239B1 (de) Pharmazeutische und/oder kosmetische Zubereitung
DE2818553A1 (de) Zusammensetzung zur behandlung von proliferativen hautkrankheiten
DE69733086T2 (de) Pharmazeutische zusammensetzungen welche kukui nuss öl enthalten
EP0847279B1 (de) Juckreizlindernde, kosmetische und/oder pharmazeutische zusammensetzungen bestehend aus einem oder mehreren leichten lokal anästhetika und einer oder mehreren adstringentien
DE3413052A1 (de) Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen
US4301145A (en) Antiseptic skin cream
DE2721831A1 (de) Entzuendungshemmende, topisch anzuwendende arzneipraeparate
EP0367103B1 (de) Topische Salbe
DE3621861A1 (de) Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
DE2947742C2 (de) Arzneimittel, enthaltend β-Cyclodextrin
DE2802924A1 (de) Heilmittel zur behandlung von akne
CH656307A5 (de) Praeparat fuer die oertliche behandlung der akne.
DE3402880A1 (de) Oel-in-wasser-creme und verfahren zu ihrer herstellung
DE2601489C2 (ja)
DE3302739A1 (de) Oxidationsstabiles mittel
DE2818827C2 (de) Mittel zur Behandlung von Psoriasis
DE2131441B2 (de) Hautbleichmittel
LU84892A1 (fr) Komposition zur reduktion der sebumsekretion
WO1989006962A1 (en) Silver sulfadiazine-containing agent for topical external therapy
DE60110897T2 (de) Der duale inhibitor der cholesterylester und wachsester synthese avasimibe zur behandlung von erkrankungen des talgdrüse

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING AKTIENGESELLSCHAFT, 13353 BERLIN, DE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee